The beta cell in autoimmune diabetes: Many mechanisms and pathways of loss

Trends in Endocrinology and Metabolism

Volumn 11, Issue 1, 2000, Pages 11-15

  Kay, Thomas W H ^a   Thomas, Helen E ^a   Harrison, Leonard C ^a   Allison, Janette ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; PERFORIN; TUMOR NECROSIS FACTOR;

APOPTOSIS; AUTOIMMUNITY; CELL DEATH; CYTOTOXIC T LYMPHOCYTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNE DISEASES; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; SIGNAL TRANSDUCTION;

EID: 0034084572     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00210-6     Document Type: Review

References (39)

1. +) T lymphocytes - clarification of their pathogenic roles in diabetes in the NOD mouse. Res. Immunol. 148:1997;320-327.
2. Kay T.W.et al. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J. Immunol. 157:1996;3688-3693.
3. Bennett S.R.et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:1998;478-480.
4. O'Brien B.A.et al. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes. 46:1997;750-757.
5. Kurrer M.O.et al. Beta cell apoptosis in T-cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 94:1997;213-218.
6. Augstein P.et al. Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Mol. Med. 4:1998;495-501.
7. Stassi G.et al. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1997;1193-1200.
8. Vaux D.L., Korsmeyer S.J. Cell death in development. Cell. 96:1999;245-254.
9. Leiter E.H.et al. The non-obese diabetic (NOD) mouse. Am. J. Pathol. 128:1987;380-383.
10. Fujino-Kurihara H.et al. Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 49:1985;107-120.
11. Rabinovitch A.et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta cells from cytokine-induced destruction. Diabetes. 48:1999;1223-1229.
12. Kagi D.et al. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186:1997;989-997.
13. Benoist C., Mathis D. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell. 89:1997;1-3.
14. Eizirik D.L.et al. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia. 39:1996;875-890.
15. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1996;1005-1029.
16. Stephens L.A.et al. Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells. Endocrinology. 140:1999;3219-3227.
17. Campbell I.L., Harrison L.C. Molecular pathology of type 1 diabetes. Mol. Biol. Med. 7:1990;299-309.
18. Thomas H.E.et al. Evidence that beta cell death in the non-obese diabetic mouse is Fas-independent. J. Immunol. 163:1999;1562-1569.
19. Campbell I.L.et al. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:1991;739-742.
20. von Herrath M.G., Oldstone M.B. Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:1997;531-539.
21. Hultgren B.et al. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:1996;812-817.
22. Wang B.et al. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 94:1997;13844-13849.
23. Thomas H.E.et al. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J. Clin. Invest. 102:1998;1249-1257.
24. Green E.A.et al. Local expression of TNF alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity. 9:1998;733-743.
25. Grewal I.S.et al. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184:1996;1963-1974.
26. Kagi D.et al. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J. Immunol. 162:1999;4598-4605.
27. Pakala S.V.et al. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J. Exp. Med. 189:1999;1053-1062.
28. Scarim A.L.et al. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta. Endocrinology. 138:1997;5301-5307.
29. Delaney C.A.et al. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology. 138:1997;2610-2614.
30. Cetkovic-Cvrlje M., Eizirik D.L. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine. 6:1994;399-406.
31. Scarim A.L.et al. Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans. Biochim. Biophys. Acta. 1361:1997;313-320.
32. Takamura T.et al. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J. Biol. Chem. 273:1998;2493-2496.
33. Corbett J.A., McDaniel M.L. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J. Exp. Med. 181:1995;559-568.
34. Chervonsky A.V.et al. The role of Fas in autoimmune diabetes. Cell. 89:1997;17-24.
35. Itoh N.et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186:1997;613-618.
36. Yamada K.et al. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia. 39:1996;1306-1312.
37. Allison J., Strasser A. Mechanisms of beta cell death in diabetes: a minor role for CD95. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13818-13822.
38. Kim Y-H.et al. Apoptosis of pancreatic beta cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur. J. Immunol. 29:1999;455-465.
39. + T lymphocytes in transgenic nonobese diabetic mice. J. Clin. Invest. 103:1999;1201-1209.